Literature DB >> 807194

Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.

I Azuma, F Kanetsuna, T Taniyama, Y Yamamura, M Hori.   

Abstract

The adjuvant activity of cell wall skeletons (mycolic acid-arabino-galactan-mucopeptide, CWS) prepared from the cells of mycobacteria, nocardia and corynebacteria was examined in vivo in mice and guinea pigs. The cell wall skeletons of Mycobacterium bovis BCG (BCG-CWS), Nocardia asteroides 131 and Corynebacterium diphtheriae PWC suspended in Freund's incomplete adjuvant (FIA) as water-in-oil emulsions showed potent adjuvant activity on the formation of circulating antibody and cell-mediated immunity to bovine serum albumin (BSA), sheep erythrocytes (SRBC) and sulfanylazo-bovine serum albumin (SA-BSA) in mice and guinea pigs. After acetylation or acid treatment, BCG-CWS retained its adjuvant activity, but the activity of BCG-CWS was destroyed completely by alkaline treatment. The cell wall constituents, arabinose-mycolate and arabino-galactan, prepared from BCG-CWS showed no adjuvant activity. It was also shown that BCG-CWS suspended in phosphate buffered saline or associated with oil droplets augmented cell-mediated cytotoxicity in which thymus-derived lymphocytes (T-cells) are effector cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807194

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  7 in total

Review 1.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

2.  Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs.

Authors:  I Saiki; K Kamisango; Y Tanio; H Okumura; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

3.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Elevated adjuvanticity of non-acid-fast mycobacteria.

Authors:  Y Kondo; T Toida
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.

Authors:  M Uemiya; K Sugimura; T Kusama; I Saiki; M Yamawaki; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.

Authors:  I Azuma; K Sugimura; T Taniyama; M Yamawaki; Y Yamamura
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).

Authors:  L A Baker; T Sharpton; P Minden; P A Campbell
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.